Meet The Team
Board of Directors
Dr. Bartley Griffith, MD
Dr. Bartley Griffith is the Thomas E. and Alice Marie Hales Distinguished Professor in Transplantation at the University of Maryland. Dr. Griffith trained at the University of Pittsburgh Medical Center under the mentorship of Henry Bahnson and Thomas Starzl. It was there that he established a basic science and clinical interest in organ replacement. Programs in mechanical circulatory support evolved from some of the earliest use of the Jarvik-7 total artificial heart as a bridge to transplantation that initiated in 1985. Subsequently, he has been involved in the evolution from paracorporeal ventricular assist devices to intra-corporeal univentricular devices. He has written extensively on the pros and cons of biventricular vs. univentricular support and of the risk factors which affect outcomes. He has been funded in the laboratory by the NHLBI since 1986, and current interests include mechanical lung and circulating support plus stem-cell treatment of heart and lung diseases.
Dr. Griffith is a principal investigator (PI) on the PumpKIN grant designed to develop a pump oxygenator for pediatric support, a PI on a PumpKIN contract with Robert Jarvik to develop and infant-size Jarvik left ventricular assist device, and is an investigator on a Phase II SBIR award to CircuLite for development of a pediatric ventricular assist device. He is the PI on an R01grant to develop an artificial lung. He is an advocate for the development of bedside bioengineers in support of patients on mechanical circulatory support and in the laboratory. He is internationally recognized for his work in heart and lung transplantation and mechanical circulation.
His current clinical role/expertise is in directing the aortic valve program at UMMC, including the PARTNER innovative, catheter-based interventional aortic valve replacement. He is a national expert in pulmonary embolism and surgical embolectomy plus thrombectomy for chronic problems. He has led the Division’s program for complex end-stage heart surgery.
He is the previous chairman of the AATS Scientific SAGR Committee and has been involved in development of the second Working Group in Cardiac Surgery with the NHLBI.
Carl A. Cohen, Esq.
Carl attended the undergraduate division of the Wharton School at the University of Pennsylvania, and then the University of Pittsburgh School of Law. Carl spent his entire career at the Buchanan Ingersoll law firm. He practiced there for over 25 years, and became the Co-Chair of the firm’s corporate section.
Carl was heavily involved early on, beginning in the late 70s, in the representation of Pittsburgh’s emerging high tech companies, many of which became western Pennsylvania success stories. A number of companies were spun out of CMU, where Carl also was a frequent guest lecturer and where he taught a course on Law and Entrepreneurship in CMU’s graduate school of business. He is also a leading lawyer in representing entrepreneurial venture capital backed companies, and was instrumental in helping to develop that part of western Pennsylvania’s economy through his work as a Board member of the Pittsburgh High Technology Council and as President of the Pittsburgh Venture Capital Association.
Marshal W. Linder
Marshal has been involved in medical device innovation for over 20 years, and led the development and commercialization of the ZOLL LifeVest, the first and only wearable defibrillator for patients at risk of sudden cardiac death. Prior to this, he held a wide range of positions with IBM, with responsibilities including hardware and software development, industrial design, systems integration, and new business development. Among other projects, Marshal led the development of the IBM Simon, considered the world’s first smartphone.
Marshal holds MS and BS degrees in electrical and computer engineering as well as a BS in physics from Clarkson University, and is an inventor on 12 US patents involving wearable medical devices.
The Breethe Clinical Advisory Board (CAB) consists of physicians recognized as leaders in the field of Lung Failure:
Matthew Bacchetta, MD, MBA, MA
Associate Professor/ Department of Thoracic Surgery
Vanderbilt University Medical Center
Surgical Director, Vanderbilt Respiratory Instutute
Director VUMC ECMO Program
Zachary Kon, M.D.
NYU Langone Health
Assistant Professor, Department of Cardiothoracic Surgery
Surgical Director, Lung Transplantation Program
Surgical Director, Pulmonary Hypertension Pulmonary Thromboendarterectomy Program
Christian Bermudez, M.D.
Associate Professor of Surgery
University of Pennsylvania
Director of Thoracic Transplantation
Surgical Director of Lung Transplantation and ECMO
Hospital of the University of Pennsylvania
Jose P. Garcia, M.D.
Indiana University Health
Transplant Surgery/ Thoracic Surgery
Daniel Brodie, M.D.
Professor of Medecine, Columbia College of Physicians and Surgeons/New York-Prosbyterian Hospital
Donald W Fallon, BSBA, MBA
Senior Vice President and Chief Financial Officer
Mr. Fallon, CPA (Inactive) has over forty years of broad senior-level financial and accounting management experience, having served in various capacities including CFO and founder of both publicly- and privately-held companies. During this time, a significant portion of his experience has been with biotechnology and biopharmaceutical companies. Mr. Fallon received his MBA in Finance from
Loyola University, Maryland, and his BS in Accounting from the University of Baltimore.
Steven J Orwig, BSME, MBA
VP of Operations
Steven has twenty years of experience in the medical device industry in research & development, product development and marketing. He began his professional career as a clinician before entering into the device industry. He has worked in large organizations like BOC/Linde, GE and in smaller venture backed companies such as Ohio Medical and Vapotherm, Inc.
His passion is working with venture start-up companies that have novel solutions that will “make a difference”.